Aequus Pharmaceuticals

(AQSZF)

By |

Profile

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.

Contact Information

Website: www.aequuspharma.ca
Main Phone: +1 604 336-7906
Address: 200 Granville Street
Address 2: Suite 2820
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6C 1S4

Issuer Information

Exchange: OTCQB
CEO: Douglas G. Janzen
Employees: 10
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.

Contact Information

Website: www.aequuspharma.ca
Main Phone: +1 604 336-7906
Address: 200 Granville Street
Address 2: Suite 2820
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6C 1S4

Issuer Information

Exchange: OTCQB
CEO: Douglas G. Janzen
Employees: 10
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.05654 $ 0. (0.00%)
Last Price 0.05654 Change $ 0. Change % 0.00 Tick N/A
Bid 0.0503 Bid Size 10,000.00 Ask 0.0592 Ask Size 100,000.00
Open N/A High N/A Low N/A Prev Close 0.05654
Last Trade Volume 0 52 Wk Hi 0.15 52 Wk Low 0.05
Market Cap 4.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 80,437,970.00 EPS (TTM) -0.03 PE Ratio N/A Exchange OTCQB